Clinical trial
A Study of GSK1325760A in Healthy Japanese Subjects
NCT00424034 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00424034 |
|---|---|
| Title | A Study of GSK1325760A in Healthy Japanese Subjects |
| Official title | Phase I Study of Ambrisentan - Single Dose Study in Healthy Japanese Male Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Subjects |
| Intervention type | Drug |
| Interventions | GSK1325760A |
| Enrollment | 32 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jan 18, 2007 |
| Last update posted | Jan 19, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: